http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2622708-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d21ddb7fd2f7217d9bd45b8e1290b25
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
filingDate 2006-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9d07b9874410e4e3c2cea43c0975e7f
publicationDate 2007-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2622708-A1
titleOfInvention Anesthesia induction and maintenance drug
abstract Disclosed herein is a combination drug designed for use by anesthesiologists for the purposes of inducing and/or maintaining general anesthesia and minimizing the stress response to pain that results from the noxious stimuli associated with surgical procedures . The present invention is suitable for use in general anesthesia to decrease the need for muscle relaxant administering and permit patients to drive themselves home after receiving the anesthetic. This invention includes a combination drug comprised of propofol (2, 6-diisopropylphenol) and remifentanil (N-phenyl-N- (4- piperidinyl) amides) in which the preferred embodiment contains 2 mcg of remifentanil for each 1 mg of propofol. The combination drug invention may include a package as two drugs of proper proportions shipped and sold in a two compartment vial or syringe for mixing immediately prior to use. Alternatively, the invention may comprise a single drug prepared with proper preservatives in an aqueous solution.
priorityDate 2005-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154084677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49852291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411818542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453918403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14049689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453595227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID47319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431909553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149253293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21696466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414024626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555159
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60815

Total number of triples: 45.